At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

Washington — The federal government has begun the process of exempting the nation’s first purpose-built robotaxi from certain safety standards so it can deploy commercially on American roads.

Registration: Free but required. Register here. VSAC’s expert outreach counselors and other professionals from around the region will offer workshops to help families navigate the college and career ...

South Korean singer and Bigg Boss 17 fame AOORA recently released Shiva Shivam (Tandava)and celebs like Daboo Malik and Mannara Chopra present at the launch praised his step towards Indian classical ...

Stroke patients face unequal access to clot-removal care; race and insurance shape transfers, even with Medicare—here’s what must change, according to Luke Messac, MD, PhD. Disparities in access to ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...

Complement-mediated hemolytic uremic syndrome (CM-HUS), commonly referred to as atypical HUS, is a rare thrombotic microangiopathy caused by uncontrolled activation of the alternative complement ...